For research use only. Not for human consumption. Not medical advice — consult a licensed clinician.

GLP-1 / Metabolic

MOTS-c

Also known as: Mitochondrial Open reading frame of the Twelve S rRNA type-c

MOTS-c is an investigational mitochondrial-derived peptide studied preclinically for metabolic regulation. It is research-only and not FDA-approved; the CB4211 analog program (CohBar) was discontinued in 2023.

Real-time market data

Pricing for MOTS-c

Live vendor pricing, normalized to $/mg so sizes compare fairly — fused with each seller's Merit trust score and latest independent COA purity. Prices refresh daily.

Average price

$4.39/mg

range $0.00–$11.60/mg

Sellers

89

from $0.00

45-day trend

-13.9%

vs 45-day avg $/mg

82 of 89 sellers have a current price· 50 stale listings hidden (not seen in 7 days)

Prices observed from public storefronts (last 24h), normalized to $/mg. "Evidence" is Merit's 0–100 Merit Score, derived only from observable verification evidence (methodology on /about); "Purity" is the latest independent COA. Some buy links are affiliate links — Merit may earn a commission at no extra cost to you, and where a vendor offers one, the code shown gets you a discount at their checkout. Affiliate status never affects price data, ranking, or the Merit Score (full policy on /disclosure). Research use only.

Independent evidence

COAs for MOTS-c

270 third-party tests across 36 vendors. Each card links to the full report.

All 270 COAs for MOTS-c →
Measured purity 98.7%–100.0% across 170 COAs
Measured purity over time
Aggregated · 3rd-party listing
99.91 %
Jul 2026
Freedom Diagnostics Moderate

For

MOTS-C

by Peptide Plugs· batch 149-01-DK

Aggregated · 3rd-party listing
99.86 %
Jun 2026
ILS Labs Strong

For

MOTS-C

by NG Peptide· batch MS40-08

Aggregated · 3rd-party listing
99.20 %
Jun 2026
Arrow Lab Solutions

For

MOTS-c

by Real Peptides· batch RP062326MC

Aggregated · 3rd-party listing
99.33 %
Jun 2026
ILS Labs Strong

For

MOTS-C

by Sunrise Bioresearch· batch MTC10MAY26-02

✓ Vendor-published
99.33 %
Jun 2026
ILS Laboratories

For

MOTS-C

by Sunrise Bioresearch· batch MTC10MAY26-02

COA on file
Aggregated · 3rd-party listing
99.48 %
Jun 2026
Freedom Diagnostics Moderate

For

MOTS-C

by Apexx Biolabs· batch Light Purple Cap-1

Aggregated · 3rd-party listing
99.35 %
Jun 2026
Kovera Labs

For

MOTS-c

by Real Peptides· batch BATCH-0322

Aggregated · 3rd-party listing
99.48 %
Jun 2026
ILS Labs Strong

For

MOTS-C

by Ion Peptide· batch MC40-06032026

Aggregated · 3rd-party listing
99.51 %
Jun 2026
ILS Labs Strong

For

MOTS-C

by Peptide Plugs· batch 127-02-DK

✓ Vendor-published
99.99 %
Jun 2026
TrustPointe Analytics Moderate

For

MOTS-C

by Peptide Partners· batch SPL-4096

COA on file
Aggregated · 3rd-party listing
99.69 %
Jun 2026
ILS Labs Strong

For

MOTS-C

by Voltera Sciences· batch MS40.05.28.26

Aggregated · 3rd-party listing
98.67 %
Jun 2026
Janoshik Analytical Limited

For

MOTS-C

by Verified Peptides· batch M005261320L

Aggregated · 3rd-party listing
99.93 %
Jun 2026
ILS Labs Strong

For

MOTS-C

by Crush Research· batch CRMTS-40-2605-2

Aggregated · 3rd-party listing
99.73 %
Jun 2026
ILS Labs Strong

For

MOTS-C

by Crush Research· batch CR-MOTS20-2605-1

Aggregated · 3rd-party listing
99.57 %
Jun 2026
ILS Labs Strong

For

MOTS-C

by Crush Research· batch CRMTS-40-2605-1

Aggregated · 3rd-party listing
99.52 %
Jun 2026
ILS Labs Strong

For

MOTS-C

by Crush Research· batch CRMTS-10-2605-1

✓ Vendor-published
99.24 %
May 2026
Kovera Labs

For

MOTS-c

by Reta One Labs· batch MTS100626

COA on file
Aggregated · 3rd-party listing
99.67 %
May 2026
Freedom Diagnostics Moderate

For

MOTS-C

by Nox Amino· batch NA-MS0226-01

Aggregated · 3rd-party listing
99.53 %
May 2026
Horizon Analytical

For

MOTS-c

by Blank Peptides· batch B-7058391-P

Aggregated · 3rd-party listing
99.04 %
May 2026
ILS Labs Strong

For

MOTS-C

by NG Peptide· batch MTS40-07

Aggregated · 3rd-party listing
99.71 %
May 2026
Freedom Diagnostics Moderate

For

MOTS-c

by Peptide Supply Co.· batch MC1005192026

Aggregated · 3rd-party listing
99.62 %
May 2026
ILS Labs Strong

For

MOTS-c

by Ion Peptide· batch MC10-05072026

Aggregated · 3rd-party listing
98.73 %
May 2026
Janoshik Analytical Limited · HPLC

For

MOTS-c

by Prime Peptides· batch 4052026MO

Aggregated · 3rd-party listing
99.78 %
May 2026
MDx BioAnalytical Laboratory Strong

For

MOTS-c

by BioLongevity Labs· batch 18-3-46154

Research depth

23 citations indexed for MOTS-c

All research on MOTS-c →

cohort · 2027

Mitophagy and Mitochondrial DNA Dynamics During Ramadan Dry Fasting vs 16:8 Time-Restricted Feeding

This study investigates how different types of fasting affect cell health, specifically focusing on how mitochondria (the energy-producing parts of cells) are cleared and renewed.

Study · 2026

Are serum MOTS-c levels and MOTS-c m.1382A>C polymorphism related to polycystic ovary syndrome?

Objective MOTS-c is a mitochondria-derived peptide associated with reduced insulin resistance and obesity. The m.1382A>C polymorphism of the MOTS-c gene is linked to an increased risk of type 2 diabetes in men.

animal · 2026

MOTS-c partially protects against skeletal muscle deterioration in C26 cachexia

Background Cancer cachexia is a multifactorial metabolic syndrome marked by progressive skeletal muscle loss, reduced function, and increased mortality. Mitochondrial dysfunction is a key driver of this phenotype.

Study · 2026

Humanin and MOTS-c Attenuate Atrial Fibrillation by Suppressing Fibrosis and Mitochondrial Dysfunction

Background: Atrial fibrillation (AF) is a common clinical arrhythmia associated with mitochondrial dysfunction, oxidative stress, and atrial fibrosis. Mitochondrial-derived peptides (MDPs), including humanin (HN) and MOTS-c, exhibit cytoprotective properties, but their role in AF remains largely unknown.

Study · 2026

Mitochondrial peptide MOTS-c suppresses systemic and cardiac inflammasome activation in a diabetic rat model

Type 2 diabetes mellitus (T2DM) is associated with chronic systemic and cardiac inflammation, contributing to the development of diabetic cardiomyopathy.

review · 2026

MOTS-c: How a secreted mitochondrial microprotein may become a potential treatment for inflammatory lung diseases

Background MOTS-c is a mitochondrial-derived microprotein (mitokine) encoded within the 12 S rRNA gene that exerts intracrine, paracrine, and endocrine effects across multiple tissues.